The content discusses the implications of GLP-1 drugs like Ozempic on patients undergoing surgeries and endoscopies, as these drugs can delay stomach emptying, leading to concerns of food being breathed into the lungs during procedures. Additionally, U.S. Sen. Bernie Sanders called on Novo Nordisk to lower the prices of its drugs after a study revealed low manufacturing costs compared to the high list prices. The study found that semaglutide injections, such as Ozempic and Wegovy, can be produced at a low cost but are sold at significantly higher prices. These issues highlight the challenges of affordability and access to essential medications.
Source link
We’re reading about a GLP-1 side effect, clinical trial transparency
